0000-00-00 |
|
|
|
External link to document |
2019-08-05 |
105 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;US RE47301 E1 ;US… 2018
1 June 2022
1:18-cv-01675
835 Patent - Abbreviated New Drug Application(ANDA)
Both |
External link to document |
2019-09-16 |
136 |
Notice of Service |
Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,106,183 B2, 8,524, 883 B2, and RE 47, 301E filed… 2018
1 June 2022
1:18-cv-01675
835 Patent - Abbreviated New Drug Application(ANDA)
Both |
External link to document |
2019-10-25 |
158 |
Claim Construction Chart |
Appendix N 883 Patent Amendment, # 15 Appendix O Patent 9,085,601, # 16 Appendix P Patent 6,403,567, # 17 Appendix… B 301 Patent, # 3 Appendix C 183 Patent, # 4 Appendix D 883 Patent, # 5 Appendix E 301 Patent Prelim …301 Patent Second Prelim Amendment, # 7 Appendix G 301 Patent Amendment, # 8 Appendix H 183 Patent Application… 883 Patent Application, # 12 Appendix L 883 Patent Prelim Amendment, # 13 Appendix M 883 Patent Amendment…Appendix Q Patent 7,671,192, # 18 Appendix R 601 Patent Application, # 19 Appendix S 601 Patent Prelim Amendment |
External link to document |
2020-05-18 |
256 |
Notice of Service |
Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,106,183 B2, 8,524,883 B2, and RE 47,301 E filed … 2018
1 June 2022
1:18-cv-01675
835 Patent - Abbreviated New Drug Application(ANDA)
Both |
External link to document |
2018-10-25 |
4 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,106,183 ;9,085,601. (nmg) (… 2018
1 June 2022
1:18-cv-01675
835 Patent - Abbreviated New Drug Application(ANDA)
Both |
External link to document |
2020-09-29 |
480 |
|
these topics. (See, e.g., United States Patent No. RE47,301) Defendants should have expected that Dr.… 2018
1 June 2022
1:18-cv-01675
835 Patent - Abbreviated New Drug Application(ANDA)
Both |
External link to document |